Evidence map›Paper›PMID 34567716›Full record

ArticleMicrosystems & nanoengineering2020

Modular operation of microfluidic chips for highly parallelized cell culture and liquid dosing via a fluidic circuit board.

A R Vollertsen, D de Boer, S Dekker, B A M Wesselink, R Haverkate, H S Rho, R J Boom, M Skolimowski, M Blom, R Passier and 3 more

Abstract read
In one paragraph

Article in Microsystems & nanoengineering, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. A Plug-and-Play Volume Minimizing Micromixer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

A R VollertsenBIOS Lab on Chip Group, MESA+ Institute for Nanotechnology, University of Twente, Enschede, The Netherlands.
D de BoerMesoscale Chemical Systems, MESA+ Institute for Nanotechnology, University of Twente, Enschede, The Netherlands.
S DekkerBIOS Lab on Chip Group, MESA+ Institute for Nanotechnology, University of Twente, Enschede, The Netherlands.
B A M WesselinkBIOS Lab on Chip Group, MESA+ Institute for Nanotechnology, University of Twente, Enschede, The Netherlands.
R HaverkateBIOS Lab on Chip Group, MESA+ Institute for Nanotechnology, University of Twente, Enschede, The Netherlands.
H S RhoInstitute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-5345-3965
R J BoomMicronit Microtechnologies, Enschede, The Netherlands.
M SkolimowskiMicronit Microtechnologies, Enschede, The Netherlands.
M BlomMicronit Microtechnologies, Enschede, The Netherlands.
R PassierApplied Stem Cell Technologies, TechMed Centre, University of Twente, Enschede, The Netherlands.
A van den BergBIOS Lab on Chip Group, MESA+ Institute for Nanotechnology, University of Twente, Enschede, The Netherlands.
A D van der Meer *Applied Stem Cell Technologies, TechMed Centre, University of Twente, Enschede, The Netherlands.
M Odijk *BIOS Lab on Chip Group, MESA+ Institute for Nanotechnology, University of Twente, Enschede, The Netherlands.ORCID 0000-0002-4467-9604

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microfluidic systems enable automated and highly parallelized cell culture with low volumes and defined liquid dosing. To achieve this, systems typically integrate all functions into a single, monolithic device as a "one size fits all" solution. However, this approach limits the end users' (re)design flexibility and complicates the addition of new functions to the system. To address this challenge, we propose and demonstrate a modular and standardized plug-and-play fluidic circuit board (FCB) for operating microfluidic building blocks (MFBBs), whereby both the FCB and the MFBBs contain integrated valves. A single FCB can parallelize up to three MFBBs of the same design or operate MFBBs with entirely different architectures. The operation of the MFBBs through the FCB is fully automated and does not incur the cost of an extra external footprint. We use this modular platform to control three microfluidic large-scale integration (mLSI) MFBBs, each of which features 64 microchambers suitable for cell culturing with high spatiotemporal control. We show as a proof of principle that we can culture human umbilical vein endothelial cells (HUVECs) for multiple days in the chambers of this MFBB. Moreover, we also use the same FCB to control an MFBB for liquid dosing with a high dynamic range. Our results demonstrate that MFBBs with different designs can be controlled and combined on a single FCB. Our novel modular approach to operating an automated microfluidic system for parallelized cell culture will enable greater experimental flexibility and facilitate the cooperation of different chips from different labs.

Indexed as

EngineeringNanoscience and technology

Identifiers

PMID34567716
PMCPMC8433198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.